Viral infections, prevalence and costs: A 5-year, hospital based, retrospective observational study in Shiraz, Iran

Pakistan Journal of Medical Sciences

Volumn 23, Issue 4, 2007, Pages 580-584

  Sabayan, Behnam ^a   Motamedifar, Mohammad ^a   Zamiri, Nima ^a   Karamifar, Kasra ^a   Chohedry, Abdolhhamid ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Prevalence; Shiraz; Viral infections

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; UNIVERSITY HOSPITAL; VIRUS INFECTION; VIRUS MENINGITIS;

EID: 34548397303     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Stein CE, Inoue M, Fat DM. The global mortality of infectious and parasitic diseases in children. Semin Pediatr Infect Dis 2004;15:125-9.
2. Shawky S. Causes of death in the Eastern Mediterranean Region during the years 1998-2000. Saudi Med J 2003;24:380-7.
3. Andrews G, Skinner D, Zuma K. Epidemiology of health and vulnerability among children orphaned and made vulnerable by HIV/AIDS in sub-Saharan Africa. AIDS Care 2006;18:269-76.
4. Aylward RB, Acharya A, England S. Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet 2003;362(9387):909-14.
5. Winter G. Global virus alert. How SARS high-lighted the risk of viral pandemics. Nurs Stand 2005;19(44): 24-6.
6. Centers for Disease Control and Prevention (CDC). Global Measles and Rubella Laboratory Network, January 2004-June 2005 MMWR Morb Mortal Wkly Rep 2005; 4(54):1100-4;
7. World Health Organization (2003), Islamic Republic of Iran, http://www.who.int/countries/irn/en/
8. Nathanson N. Virus perpetuation in populations: biological variables that determine persistence or eradication. Arch Virol Suppl 2005;(19):3-15.
9. WHO. International Statistical Classification of Diseases, 10th Revision, Second Edition 2003.
10. Jawetz, Melnick, Adelberg's. Medical Microbiology. 23rd Ed; McGraw-Hill Company 2004;394.
11. Al-Mazrou YY, Musa EK, Abdalla MN. Disease burden and case management of bacterial meningitis among children under 5 years of age in Saudi Arabia. Saudi Med J 2003;24(12):1300-7.
12. Balfour HH Jr. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Scand J Infect Dis Suppl 1991;80:69-74.
13. Meister W, Neiss A, Gross G, Doerr H, Hobel W, Malin J. Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology 1998;41(6):272-7.
14. Motamedifar M, Handjani F, Hadi N, Shahkarami MK, Mehrabani D. Seroprevalence of Varicella-Zoster Virus in Children from Shiraz Iran. Iran J Immunol 2006;3(1):43-6.
15. Steinke DT, Weston TL, Morris AD. Epidemiology and economic burden of viral hepatitis: an observational Population based study. Gut 2002;50(1):100-5.
16. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34 Suppl 1:S1-3.
17. Bojuwoye BJ. The burden of viral hepatitis in Africa. West Afr J Med 1997;16 (4):198-203.
18. Deuffic-Burban S, Wong JB, Valleron AJ. Comparing the public health burden of chronic hepatitis C and HIV infection in France. J Hepatol 2004;40(2):319-26.
19. Bair RM. Prevalence and risk factors for hepatitis C virus infection among adolescents in detention. Arch Pediatr Adolesc Med 2005;159:1015-8.
20. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis 1997;1:559-68.
21. Qureshi H, Shahid A, Mujeeb SA. Exposer rate of hepatitis E (IgG) in a selected population of children and adults in Karachi. J Pak Med Assoc 2000;50(10):352-4.
22. Pettifor AE, Van der Straten A, Dunbar MS. Early age of first sex: A risk factor for HIV infection among women in Zimbabwe AIDS 2004;18:1435-42.
23. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004;11 Suppl 1:24A-35A.
24. Walter J, Radun D, Claus H. Hepatitis B and C risk factors in Germany - results of the national surveillance. Gesundheitswesen 2005;67:441-7.